The WT1 gene, responsible for encoding the transcription factor Wilms tumour suppressor 1, is involved in the formation and management of podocytes, and mutations in this gene have also been associated with early-onset NS, syndromic and non-syndromic NS, with a progression to ESKD [12]. This evidence concerns the gene WT1 and Netherton syndrome.